Skip to main content
Clinical Trials/NL-OMON37156
NL-OMON37156CompletedNot Applicable

Observational Study of Optical Coherence Tomography (OCT) in Patients Undergoing Fractional Flow Reserve (FFR) and Percutaneous Coronary Intervention (PCI) - ILUMIEN I

St. Jude Medical0 sites25 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
25

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • 1. Age >= 18 years
  • 2. Patient provides signed written informed consent before any studyspecific procedure
  • 3. De novo coronary artery disease in target vessel
  • 4. Single of multi vessel disease. For multi vessel disease up to two vessels and three lesions treated, with no more than two lesions per vessel. Vessel is defined as left anterior descending, left circumflex, and right coronary arteries. Any branch within the vessel in considered part of the vessel.
  • 5. Elective or ad hoc PCI, stabe angina, acute coronary syndrome (unstable angina and NSTEMI)
  • 6. Angiographically significant (>50% visiual estimation) stenosis present in at least one native coronary artery
  • 7. Mandatory use of FFR and OCT pre and post PCI. PCI strongly recommended in subjects with an FFR<=0.80 in target vessel

Exclusion Criteria

  • 1. Subjects with STEMI, emergent PCI, or in cardiogenic shock
  • 2. Subjects with target left main lesion
  • 3. Subjects with restenosis or stent thrombosis in the target vessel
  • 4. Plannen use of bare metal stent
  • 5. Known renal insufficiency (examples being but not limited to eGFR<60ml/kg/m2, serum creatinine >=2.5 mg/dL, or on dialysis)
  • 6. Aorto-ostial lesion location within 3 mm of the aorta junction (both right and left)
  • 7. Extrene angulation (>90%) or excessive tortuosity (>45degree angles) proximal to or within the target lesion
  • 8. Vessel(s) and lesion(s) non amenable for PC, for examples diffuse disease
  • 9. Anu other medical condition that in the opinion of the investigator will interfere with patient safety or study results

Investigators

Similar Trials

Observational Study of Optical Coherence... | Clinical Trial